SCHEMBL20534655

SCHEMBL20534655

CC(CCC(=O)O)c1ccccn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.49
CYP1A2 P05177 3/20 0.49
CYP3A4 P08684 2/20 0.46
CYP2C19 P33261 3/20 0.45
TSHR P16473 3/20 0.45
KDM4E B2RXH2 2/20 0.45
LMNA P02545 1/20 0.45
RAB9A P51151 1/20 0.45
KMO O15229 2/20 0.43
SLC6A2 P23975 2/20 0.43
SLC6A4 P31645 2/20 0.43
CHRM2 P08172 1/20 0.43
SCN1A P35498 1/20 0.43
SCN2A Q99250 1/20 0.43
SCN3A Q9NY46 1/20 0.43
MEN1 O00255 1/20 0.42
GAA P10253 1/20 0.42
KMT2A Q03164 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
SLC6A3 Q01959 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16561481 0.85 CYP3A4 (0.45) ALDH1A1CYP1A2CYP3A4CYP2C19TSHR
SCHEMBL25152686 0.83 CYP1A2 (0.51) ALDH1A1CYP1A2CYP3A4CYP2C19TSHR
SCHEMBL1209089 0.83 CYP1A2 (0.51) ALDH1A1CYP1A2CYP3A4CYP2C19TSHR
SCHEMBL14292125 0.83 KCNA5 (0.48) ALDH1A1CYP1A2CYP3A4CYP2C19TSHR
SCHEMBL16477945 0.80 KCNA5 (0.53) ALDH1A1CYP1A2CYP3A4TSHRLMNA
SCHEMBL20034107 0.80 KCNA5 (0.53) ALDH1A1CYP1A2CYP3A4TSHRLMNA
SCHEMBL1156021 0.80 KCNA5 (0.53) ALDH1A1CYP1A2CYP3A4TSHRLMNA
SCHEMBL22060302 0.80 KCNA5 (0.53) ALDH1A1CYP1A2CYP3A4TSHRLMNA
SCHEMBL25447692 0.80 TSHR (0.47) ALDH1A1CYP1A2CYP3A4CYP2C19TSHR
SCHEMBL20099923 0.80 TSHR (0.47) ALDH1A1CYP1A2CYP3A4CYP2C19TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3609869-A1 SUBSTITUTED N-ARYLETHYL-2-ARYLQUINOLINE-4-CARBOXAMIDES AND USE THEREOF Bayer Aktiengesellschaft (DE) 2020-02-19 EP disclosed
WO-2018189011-A1 SUBSTITUTED N-ARYLETHYL-2-ARYLQUINOLINE-4-CARBOXAMIDES AND USE THEREOF BAYER AKTIENGESELLSCHAFT (DE) 2018-10-18 WO disclosed